A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2001
11/28/2001	EP0853483A4 Novel peptides
11/28/2001	EP0845032B1 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
11/28/2001	EP0789588A4 Method for making a medicament for treating secondary immunodeficiency
11/28/2001	EP0787726B1 Novel compound, process for producing the same, and antitumor agent
11/28/2001	EP0698108B1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/28/2001	EP0690712B1 Taxanes having a pyridyl substituted side-chain
11/28/2001	EP0512076B1 Method of treating cancer using structured lipids
11/28/2001	CN1324406A DNA molecules encoding MUC-1 and use thereof in tumor vaccination
11/28/2001	CN1324405A Novel G protein-coupled receptor proteins, DNAS thereof and ligands to the same
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324374A Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties
11/28/2001	CN1324360A Bicyclic nitrogen heterocycles
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324352A 2-phenylpyran-4-one derivatives
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1324258A Aglyco products and method of use
11/28/2001	CN1324245A Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents
11/28/2001	CN1324242A Novel NEUROPILIN/growth factor binding and use thereof
11/28/2001	CN1324241A Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
11/28/2001	CN1323889A New polypeptide-human sailer transposase 11 and polynucleotides for coding same
11/28/2001	CN1323827A New polypeptide-human transcriptional activation protein subunit 14 and polynucleotides for coding same
11/28/2001	CN1323816A New polypeptide-human L1 reverse transcription factor 22 and polynucleotides for coding same
11/28/2001	CN1323813A New polypeptide-neural syndesis ion channel related protein 11 and polynucleotides for coding same
11/28/2001	CN1323804A New polypeptide-human ribosome SII protein 12 and polynucleotides for coding same
11/28/2001	CN1323802A New human protein with the function of inhibiting cancer cell growth and its coding sequence
11/28/2001	CN1323604A Foamed disease-treating ointment
11/28/2001	CN1323589A Cancer treating and tumor-eliminating traditional Chinese medicine
11/28/2001	CN1075501C Camptothecin derivatives, prepn. method, intermediate and uses
11/28/2001	CN1075500C Process of prepn. novel coumaric quinolone carboxylic acid and uses thereof
11/28/2001	CN1075389C Sol prepn. of rhenium nucleic labeled iodanated oil and its preparing process and application
11/28/2001	CN1075387C Antitumor agent potentiator comprising IL-6 antagonist
11/28/2001	CN1075378C Traditional Chinese medicine emulsion for anti cancer and prepn. method thereof
11/28/2001	CN1075377C Composite mannosans peptides oral liquor
11/28/2001	CN1075356C Xianggu mushroom tea and method for producing same
11/27/2001	US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323228 3-substituted indole angiogenesis inhibitors
11/27/2001	US6323200 The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the t-helper-type 2 immune response.
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001	US6323181 Antitumor agents
11/27/2001	US6323028 Isolated peptides which comply with HLA-CW16 molecules and uses
11/27/2001	US6323003 Compositions and methods for activating genes of interest
11/27/2001	US6322791 Haemopoietic growth factor antagonists and uses therefor
11/27/2001	US6322790 Treatment of primary and metastatic noeplastic diseases and infectious diseases; administering antigen presenting cells sensitized with complexes of hsps noncovalently bound to an antigenic molecule
11/27/2001	US6322787 Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells
11/27/2001	US6322770 Indazole vitronectin receptor antagonist pharmaceuticals
11/27/2001	CA2214037C Method of making camptothecin and camptothecin analogs
11/27/2001	CA2079685C Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
11/27/2001	CA2021329C Di-aromatic esters, process for their preparation and use in human or veterinary medicine and as cosmetic compositions
11/27/2001	CA1341323C Method and composition for preventing growth and replication of cancer cells that express the core structure of a mucin-type glycoprotein
11/26/2001	CA2316405A1 Modulation of inflammation by protease products
11/22/2001	WO2001088546A2 Treatments and markers for cancers of the central nervous system
11/22/2001	WO2001088138A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001	WO2001088131A1 Regulation of mt1-mmp activity
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088126A2 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
11/22/2001	WO2001088124A2 Method and reagent for the inhibition of erg
11/22/2001	WO2001088119A1 Novel g protein-coupled receptor protein and dna thereof
11/22/2001	WO2001088116A2 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088106A2 Novel deoxyribonucleside kinase enzyme multi-substrate variants
11/22/2001	WO2001088105A2 Production of dendritic cells from bone-marrow stem cells
11/22/2001	WO2001088097A1 Immune potentiating compositions
11/22/2001	WO2001087982A2 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	WO2001087979A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087977A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087966A1 A new polypeptide-human pax protein 22 and the polynucleotide encoding it
11/22/2001	WO2001087964A1 A new polypeptide- human gap connexin 15 and the polynucleotide encoding it
11/22/2001	WO2001087963A1 A new polypeptide- human ribosomal protein s18-12 and the polynucleotide encoding it
11/22/2001	WO2001087962A1 A new polypeptide-human pax protein 11 and the polynucleotide encoding it
11/22/2001	WO2001087961A1 A new polypeptide-human pax protein 11.4 and the polynucleotide encoding it
11/22/2001	WO2001087960A1 A new polypeptide-human kruppel-related dna-binding protein 10 and the polynucleotide encoding it
11/22/2001	WO2001087959A1 A new polypeptide-human pax protein 11.9 and the polynucleotide encoding it
11/22/2001	WO2001087956A1 A novel polypeptide - deae and deah box family atp-dependent helicase 50 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087955A1 A novel polypeptide-dna mismatch repair protein 10 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087950A1 A novel polypeptide -human cannabinoid receptor 11 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087949A1 A novel polypeptide- human pax protein 9 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087948A1 A novel polypeptide -human aldehyde/ketoreductase 12 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087947A1 A novel polypeptide-human ccr4 protein 10 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087945A1 The novel polypeptide-human laminin b2 chain 12 and the polynucliotide encoding said polypeptide
11/22/2001	WO2001087944A1 A novel polypeptide-human protein 10 characterized in that it comprises the sequence of gamma glutamyl transpeptidase and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087943A1 A novel polypeptide-human atp-dependent serine protease 13 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087942A1 A novel polypeptide -human phosphatidase 13 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087941A1 A novel polypeptide-human kringle protein 14 and the polynucleotide encoding said polypeptide
11/22/2001	WO2001087935A2 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
11/22/2001	WO2001087934A2 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides
11/22/2001	WO2001087928A1 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
11/22/2001	WO2001087895A1 Synthetic process for the manufacture of an ecteinaschidin compound
11/22/2001	WO2001087894A1 Antitumoral analogs of et-743
11/22/2001	WO2001087890A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
11/22/2001	WO2001087887A2 Neuroprotective and anti-proliferative compounds
11/22/2001	WO2001087883A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087874A1 Process for producing crystal
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087869A1 A pharmaceutical composition containing the extract of saururus chinensis baill useful as and anticancer agent and a process for the preparation thereof
11/22/2001	WO2001087854A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors

1 ... 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 ... 2211